We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Developing More Efficient Biologic Workflows with Automated Plasmid Preps and Protein/Antibody Purification

Nidhi Nath, PhD

Dr. Nath is a Group Leader in Protein and Nucleic Acid Purification at Promega Corporation leading development of new tools for antibody and protein purification and functional analysis. Dr Nath has a PhD in Biomedical Engineering from Indian Institute of Technology, Dehli, India

Doug White

Doug White graduated from University of Wisconsin Madison with a Master's Degree in Biochemistry and had been a Promega scientist for 25 years. While at Promega, he has developed multiple key products including PepTag®, IsoQuant®, PureYield™, Midi and Maxipreps, and various ReliaPrep™ Nucleic Acid Purification kits.

Chris D'Jamoos

Chris D'Jamoos, MS, is a Strategic Collaboration Manager at Promega Corporation. He has worked for the last 20 years introducing new and emerging technologies to the life sciences industry. His expertise includes liquid handling automation, PCR/qPCR, NGS, single cell biology, and continuous flow bioprocessing. Currently, Chris combines his knowledge of the latest Promega purification chemistries with the most advanced liquid handling automation systems available, to improve processes for manufacturing of biologics while advancing science in the area of CRISPR and NGS.

  • Dr. Nidhi Nath, Doug White and Chris D'Jamoos

  • Promega Corporation

Tuesday, May 14, 2019

Development and screening of biologics can be a time-consuming process due to the volume of samples processed for cloning, isolation of plasmids and purification of candidate antibodies. This webinar will discuss how our field-based automation team can help you develop walk-away automation solutions to speed up your purification workflow.

Additional Webinar Information:

Developing therapeutic proteins can be a labor-intensive process, with multiple cloning and screening steps required for identification and testing of potential therapeutic molecules. Learn how Promega reagents for plasmid and protein purification have been developed and installed on laboratory liquid handlers. Promega solutions include the capability to fully automate plasmid mini and midi preps, as well as screening-scale antibody purification, allowing more efficient use of resources and streamlining the drug development workflow.